valerates has been researched along with sf 6,5 in 6 studies
Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (sf 6,5) | Trials (sf 6,5) | Recent Studies (post-2010) (sf 6,5) |
---|---|---|---|---|---|
2,251 | 294 | 457 | 7 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alon, R; Cahalon, L; Greenspoon, N; Hardan, I; Hershkoviz, R; Lider, O; Reich, S; Slavin, S; Weiss, L | 1 |
Aeed, H; Bruck, R; Greenspoon, N; Halpern, Z; Hershkoviz, R; Lider, O | 1 |
Greenspoon, N; Hershkoviz, R; Lider, O; Melamed, S | 1 |
Aeed, H; Barg, J; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Matas, Z; Zaidel, L | 1 |
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Kenet, G; Lider, O; Matas, Z; Shirin, H; Zaidel, L | 1 |
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H | 1 |
1 review(s) available for valerates and sf 6,5
Article | Year |
---|---|
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates | 2000 |
5 other study(ies) available for valerates and sf 6,5
Article | Year |
---|---|
Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic Arg-Gly-Asp mimetics.
Topics: Animals; Cell Adhesion; Dipeptides; Female; Fibronectins; Glycoproteins; Guanidines; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Valerates; Vitronectin | 1993 |
Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope.
Topics: Animals; Cell Adhesion; Concanavalin A; Epitopes; Extracellular Matrix; Fibronectins; Guanidines; Immunity, Cellular; Laminin; Liver; Male; Mice; Mice, Inbred BALB C; Molecular Mimicry; Oligopeptides; Receptors, Immunologic; T-Lymphocytes; Valerates | 1995 |
Nonpeptidic analogues of the Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin.
Topics: Antibodies, Monoclonal; beta-Alanine; Caproates; Cell Adhesion; Cell Division; Dose-Response Relationship, Drug; Eye; Fascia; Fibroblasts; Fibronectins; Guanidines; Humans; Integrins; Laminin; Oligopeptides; Valerates | 1994 |
Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Biopsy; Carcinogens; Cell Adhesion; Disease Progression; Extracellular Matrix; Female; Fibronectins; Guanidines; Hemodynamics; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Oligopeptides; Rats; Rats, Wistar; Spleen; Thioacetamide; Valerates | 1996 |
Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Concanavalin A; Guanidines; Hepatitis, Animal; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha; Valerates | 1997 |